News

Greater Bay Area International Clinical Trial Institute (GBAICTI) participated in a sharing session hosted by the Hospital Authority on July 31, 2025, which brought together around 100 representatives from over 30 companies. During the session, Hospital Authority representatives outlined a series of enhancement measures to promote clinical research development, including the recently implemented new streamlined approval procedures aimed at attracting more clinical research projects from the industry. In addition, Professor Bernard Cheung, CEO of GBAICTI, shared his views on the development and outlook of clinical trials in Hong Kong. The event provided an in-depth interactive platform, allowing GBAICTI to better understand industry needs and foster collaboration.